GB2162522A — An indole derivative
Assigned to Glaxo Group Ltd · Expires 1986-02-05 · 40y expired
What this patent protects
A compound of formula (I> <IMAGE> and its physiologically acceptable salts and solvates are described as useful in treating and/or preventing pain resulting from dilation of the cranial vasculature, in particular migraine. The compound (I) may be prepared, for example, b…
USPTO Abstract
A compound of formula (I> <IMAGE> and its physiologically acceptable salts and solvates are described as useful in treating and/or preventing pain resulting from dilation of the cranial vasculature, in particular migraine. The compound (I) may be prepared, for example, by cyclising a compound of formula (II> <IMAGE>
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.